Holen Sie sich die Stockscreener-App
9.20
2.56%
0.23
Handel nachbörslich:
9.20
Arvinas Inc Aktie (ARVN) Neueste Nachrichten
D. E. Shaw adjusts Arvinas (ARVN) stake as one entity falls below 5% - Stock Titan
Arvinas (ARVN) Q2 2026 Earnings Call Transcript - AOL.com
ARVN Stock Jumps 10% After FDA Approves Breast Cancer Drug A Month Ahead Of Schedule - Stocktwits
Enterprise value to EBITDA forward of Arvinas, Inc. – NASDAQ:ARVN - TradingView
ARVN Maintains by Evercore ISI Group -- Price Target Lowered to $14.00 - GuruFocus
ARVN Maintained by Citigroup -- Price Target Lowered to $21.00 - GuruFocus
Morgan Stanley Maintains Arvinas(ARVN.US) With Hold Rating, Maintains Target Price $10 - moomoo.com
A Quick Look at Today's Ratings for Arvinas(ARVN.US), With a Forecast Between $10 to $21 - Moomoo
Arvinas, Inc. Stock 12‑Month Price Target Cut to $13.93, Implies 59% Upside - TradingView
Precision Trading with Arvinas Inc. (ARVN) Risk Zones - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), 10x Genomics (TXG) and Teleflex (TFX) - The Globe and Mail
Arvinas (NASDAQ:ARVN) Rating Increased to Hold at Wall Street Zen - MarketBeat
Arvinas Inc (ARVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BofA Securities Maintains Arvinas(ARVN.US) With Hold Rating - Moomoo
Arvinas (NASDAQ:ARVN) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Arvinas, Inc. (ARVN) stock price, news, quote and history - Yahoo Finance Australia
HC Wainwright Has Pessimistic Outlook of Arvinas Q3 Earnings - MarketBeat
Arvinas Inc (ARVN) Stock News Today - TradingKey
Analysts Are Bullish on These Healthcare Stocks: Bruker (BRKR), Arvinas Holding Company (ARVN) - The Globe and Mail
Arvinas (ARVN) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
H.C. Wainwright Maintains Arvinas(ARVN.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Arvinas Holding Earnings Call: PROTAC Milestone and Outlook - The Globe and Mail
Transcript: Arvinas Q2 2026 Earnings Conference Call - Sahm
Arvinas (NASDAQ:ARVN) Trading Down 7.8% on Analyst Downgrade - MarketBeat
ARVN Maintains Neutral Rating by Wedbush -- Price Target Raised to $12 - GuruFocus
Arvinas Q2 2026 earnings: Licensing revenue drives a return to profit - TradingKey
BTIG reiterates Arvinas stock Buy rating on pipeline execution By Investing.com - Investing.com UK
Arvinas, Inc. Stock 12‑Month Price Target Cut to $14.85, Implies 84% Upside - TradingView
Arvinas, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
ARVN Reiterated by BTIG -- Price Target Maintained at $18.00 - GuruFocus
Arvinas (NASDAQ: ARVN) posts $169.4M profit on VEPPANU and Rigel deals - Stock Titan
ARVINAS, INC. 2026: Revenue $249.7M, EPS $2.58— 10-Q Summary - TradingView
BTIG reiterates Arvinas stock Buy rating on pipeline execution - Investing.com
BTIG Research Reiterates Buy Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
Arvinas' (ARVN) "Equal Weight" Rating Reaffirmed at Wells Fargo & Company - marketbeat.com
Earnings call transcript: Arvinas Q2 2026 profit beat lifts outlook - Investing.com
Wedbush Adjusts Price Target on Arvinas to $12 From $11, Maintains Neutral Rating - finance.yahoo.com
Arvinas (NASDAQ:ARVN) Trading 14.8% Higher Following Better-Than-Expected Earnings - MarketBeat
Arvinas Q2 Earnings Call Highlights - MarketBeat
Arvinas (NASDAQ:ARVN) Releases Earnings Results, Beats Expectations By $2.95 EPS - MarketBeat
Arvinas Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Arvinas, Inc. (ARVN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
ARVINAS ($ARVN) Releases Q2 2026 Earnings - Quiver Quantitative
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Arvinas reports $249.7M Q2 revenue, $169.4M net income and guidance into H2 2028 - TradingView
Arvinas Q2 2026 Earnings Call Transcript - MarketBeat
ARVN: FDA approval, major out-licensing, and pipeline focus drive strong Q2 results and outlook - TradingView
Earnings To Watch: Arvinas Inc (ARVN) Q2 2026 -- GF Value Sees 34% Upside - Yahoo Finance
Arvinas (ARVN) Projected to Announce Quarterly Earnings on Wednesday - marketbeat.com
Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026 - The Manila Times
Arvinas to give corporate update during Aug. 4 webcast - Stock Titan
ARVN|Arvinas Inc|Price:8.220|Chg%:+0.190 - TradingKey
Arvinas Inc (ARVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Arvinas Inc (ARVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Arvinas, Inc. $ARVN is Rangeley Capital LLC's 8th Largest Position - MarketBeat
Arvinas Inc (ARVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arvinas (NASDAQ:ARVN) Upgraded at Wall Street Zen - MarketBeat
TradingKey - TradingKey
Arvinas Inc (ARVN) Balance Sheet - TradingKey
Caxton Associates LLP Decreases Stake in Arvinas, Inc. $ARVN - MarketBeat
ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff - Stocktwits
Arvinas, Inc. (NASDAQ:ARVN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):